EP11.03. Prognostic Value of Body Mass Index and Serum Lipid for First-line Immunotherapy in Patients with Advanced NSCLC: A Retrospective Study - PDF(Slides)
Back to course
Pdf Summary
Asset Subtitle
Yanxin Sun
Meta Tag
Speaker Yanxin Sun
Topic Metastatic NSCLC: Immunotherapy - Retrospective
Keywords
retrospective study
prognostic value
body mass index
BMI
serum lipids
non-small cell lung cancer
NSCLC
first-line immunotherapy
overweight patients
progression-free survival
Powered By